In-Hospital Mortality and Prediction in an Urban U.S. Population With COVID-19

Vinod Rustgi1,2, Michael Makar3, Carlos D Minacapelli1,2

  • 1Medicine, Division of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson Medical School, New Brunswick, USA.

Cureus
|January 7, 2021
PubMed

Insights

This study developed a COVID-19 mortality risk calculator using clinical, laboratory, and imaging data. The tool aids in predicting in-hospital mortality for diverse urban populations.

Area of Science:

  • Medicine
  • Public Health
  • Epidemiology

Background:

  • Coronavirus disease 2019 (COVID-19) significantly impacted global health, necessitating tools for clinical decision-making.
  • Understanding factors influencing COVID-19 disease severity and in-hospital mortality is crucial for patient management.

Purpose of the Study:

  • To develop and validate a risk stratification model for predicting in-hospital mortality in COVID-19 patients.
  • To identify key clinical, laboratory, and radiologic variables associated with severe outcomes and mortality in a diverse urban population.

Main Methods:

  • Retrospective analysis of electronic medical records from 403 COVID-19 patients at Robert Wood Johnson University Hospital.
  • Utilized least absolute shrinkage and selection operator (LASSO) regression to identify significant predictors of in-hospital mortality.
  • Excluded pregnant patients, transfers, and those discharged from the emergency room.

Main Results:

  • Identified key predictors of in-hospital mortality including abnormal CT scan/chest X-ray, chronic kidney disease, age, white blood cell count, platelet count, alanine aminotransferase, and aspartate transaminase.
  • Developed a risk calculator with a sensitivity of 82%, specificity of 72%, and negative predictive value of 93%.
  • The identified factors are particularly relevant to urban, highly diverse populations in the United States.

Conclusions:

  • The developed risk calculator is a valuable tool for stratifying COVID-19 patient mortality risk.
  • Clinical, laboratory, and radiologic data are critical for predicting severe outcomes in COVID-19 patients.
  • This model can support clinical decision-making and resource allocation in managing COVID-19 patients.

Related Concept Videos

Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
194
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
614
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
96
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
122
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
504
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
589